Andrew Ashe

Andrew Ashe

President presso VERVE THERAPEUTICS, INC.

Patrimonio netto: 4 M $ in data 31/03/2024

57 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Andrew D.
Ashe
is currently the President, COO & General Counsel at Verve Therapeutics, Inc. Prior to his current position, he held the role of General Counsel at Beacon Therapeutics (USA), Inc. from 2017 to 2018.
Before that, he served as Secretary, Executive VP & General Counsel at Dyax Corp.
from 2015 to 2016.
Additionally, Mr. Ashe was a Member-Business Law Practices at Nutter McClennen & Fish LLP and Prince Lobel Tye LLP.
He obtained his undergraduate degree from the University of Massachusetts and his graduate degree from George Washington University Law School.
He also holds an undergraduate degree from The Isenberg School of Management.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
14/02/2024 266 509 ( 0.34% ) 4 M $ 31/03/2024

Posizioni attive di Andrew Ashe

Precedenti posizioni note di Andrew Ashe

SocietàPosizioneFine
APPLIED GENETIC TECHNOLOGIES CORPORATION General Counsel 01/08/2018
DYAX CORP. Chief Administrative Officer 01/01/2016
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Andrew Ashe

Formazione di Andrew Ashe

The Isenberg School of Management Undergraduate Degree
George Washington University Law School Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Andrew Ashe

Relazioni

59

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
VERVE THERAPEUTICS, INC.

Health Technology

Aziende private4

Health Technology

Commercial Services

Health Technology

Commercial Services

Vedi le connessioni aziendali